These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 38518893

  • 1. Pre-chemoradiotherapy high platelet counts predict jaw osteoradionecrosis in locally advanced nasopharyngeal carcinoma patients.
    Somay E, Topkan E, Kucuk A, Ozturk D, Ozkan EE, Ozdemir BS, Besen AA, Mertsoylu H, Pehlivan B, Selek U.
    J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101838. PubMed ID: 38518893
    [Abstract] [Full Text] [Related]

  • 2. Pre-chemoradiotherapy low hemoglobin levels indicate increased osteoradionecrosis risk in locally advanced nasopharyngeal cancer patients.
    Yilmaz B, Somay E, Topkan E, Pehlivan B, Selek U.
    Eur Arch Otorhinolaryngol; 2023 May; 280(5):2575-2584. PubMed ID: 36749372
    [Abstract] [Full Text] [Related]

  • 3. Valero's host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients.
    Topkan E, Somay E, Yilmaz B, Pehlivan B, Selek U.
    BMC Cancer; 2023 Jul 12; 23(1):651. PubMed ID: 37438683
    [Abstract] [Full Text] [Related]

  • 4. The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy.
    Yilmaz B, Somay E, Topkan E, Kucuk A, Pehlivan B, Selek U.
    BMC Oral Health; 2023 Apr 20; 23(1):231. PubMed ID: 37081475
    [Abstract] [Full Text] [Related]

  • 5. Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma.
    Kubota H, Miyawaki D, Mukumoto N, Ishihara T, Matsumura M, Hasegawa T, Akashi M, Kiyota N, Shinomiya H, Teshima M, Nibu KI, Sasaki R.
    Radiat Oncol; 2021 Jan 05; 16(1):1. PubMed ID: 33402192
    [Abstract] [Full Text] [Related]

  • 6. Preradiation tooth extraction and jaw osteoradionecrosis: Nationwide population-based retrospective study in Taiwan.
    Liao PH, Chu CH, Tang PL, Wu PC, Kuo TJ.
    Clin Otolaryngol; 2020 Nov 05; 45(6):896-903. PubMed ID: 32738824
    [Abstract] [Full Text] [Related]

  • 7. Utility of pre-chemoradiotherapy Pan-Immune-Inflammation-Value for predicting the osteoradionecrosis rates in locally advanced nasopharyngeal cancers.
    Yilmaz B, Somay E, Topkan E, Kucuk A, Pehlivan B, Selek U.
    Strahlenther Onkol; 2023 Oct 05; 199(10):910-921. PubMed ID: 37566126
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Home enteral nutrition may prevent myelosuppression of patients with nasopharyngeal carcinoma treated by concurrent chemoradiotherapy.
    Li X, Zhou J, Chu C, You Q, Zhong R, Rao Z, Hu W.
    Head Neck; 2019 Oct 05; 41(10):3525-3534. PubMed ID: 31301097
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Baseline Low Prognostic Nutritional Index Predicts Poor Survival in Locally Advanced Nasopharyngeal Carcinomas Treated With Radical Concurrent Chemoradiotherapy.
    Topkan E, Yucel Ekici N, Ozdemir Y, Besen AA, Mertsoylu H, Sezer A, Selek U.
    Ear Nose Throat J; 2021 Feb 05; 100(2):NP69-NP76. PubMed ID: 31184210
    [Abstract] [Full Text] [Related]

  • 13. Jaw osteoradionecrosis and dental extraction after head and neck radiotherapy: A nationwide population-based retrospective study in Taiwan.
    Kuo TJ, Leung CM, Chang HS, Wu CN, Chen WL, Chen GJ, Lai YC, Huang WC.
    Oral Oncol; 2016 May 05; 56():71-7. PubMed ID: 27086489
    [Abstract] [Full Text] [Related]

  • 14. Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model.
    Liu W, Yu B, Luo Y, Li J, Yuan X, Wu S, Liang B, Lv Z, Li Y, Peng X, Lu J, Peng X, Liu X.
    BMC Cancer; 2021 May 29; 21(1):639. PubMed ID: 34051750
    [Abstract] [Full Text] [Related]

  • 15. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.
    Setakornnukul J, Thephamongkhol K.
    BMC Cancer; 2018 Mar 27; 18(1):329. PubMed ID: 29587665
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.